Yılmaz Mehmet F, Karagöz Ali, Zeren Gönül, Avcı İlhan I, Timur Barış, Sungur Mustafa A, Kalkan Sedat, Şimşek Barış, Can Fatma, Acar Emrah, Tanboğa İbrahim H, Karabay Can Y
Department of Cardiology, Dr Siyami Ersek Thoracic and Cardiovascular Surgery Research and Training Hospital, İstanbul, 34668, Turkey.
Department of Cardiology, Kosuyolu Kartal Heart Training and Research Hospital, Istanbul, 34865, Turkey.
Biomark Med. 2022 Oct;16(14):1043-1053. doi: 10.2217/bmm-2022-0241. Epub 2022 Sep 5.
Diabetes, hypertension, hyperlipidemia and smoking are associated with coronary artery disease and ST-elevation myocardial infarction (STEMI). However, patients without any classic risk factors have a higher mortality rate in the post-STEMI period. The aim of this study was to investigate the relationship between in-hospital mortality and creatinine/albumin ratio in patients with STEMI without modifiable risk factors. All patients included in this study with a diagnosis of STEMI and who underwent primary percutaneous intervention between 2016 and 2020 were retrospectively analyzed. Patients were included in the standard modifiable cardiovascular risk factor (SMuRF) group if at least diabetes, hypertension, smoking or hyperlipidemia was present according to risk factors. Patients without these risk factors were considered the non-SMuRF group. Creatinine/albumin ratio was found to be higher in non-SMuRF patients with mortality (p < 0.001). In multivariate logistic regression analysis, ejection fraction, hemoglobin and SMuRF were found to be inversely associated with in-hospital mortality (odds ratio [OR]: 0.48, 95% CI: 0.35-0.66, p < 0.001; OR: 0.70, 95% CI: 0.56-0.88, p = 0.002; OR: 0.57, 95% CI: 0.34-0.95, p = 0.03, respectively). The creatinine/albumin ratio can be used as a predictor of mortality in these patients; it can help identify high-risk patients beforehand.
糖尿病、高血压、高脂血症和吸烟与冠状动脉疾病及ST段抬高型心肌梗死(STEMI)相关。然而,没有任何经典危险因素的患者在STEMI后时期的死亡率更高。本研究的目的是调查无可控危险因素的STEMI患者住院死亡率与肌酐/白蛋白比值之间的关系。对本研究纳入的所有在2016年至2020年间诊断为STEMI并接受了直接经皮冠状动脉介入治疗的患者进行回顾性分析。根据危险因素,如果患者至少存在糖尿病、高血压、吸烟或高脂血症,则将其纳入标准可控心血管危险因素(SMuRF)组。没有这些危险因素的患者被视为非SMuRF组。发现非SMuRF组中死亡患者的肌酐/白蛋白比值更高(p<0.001)。在多因素逻辑回归分析中,发现射血分数、血红蛋白和SMuRF与住院死亡率呈负相关(比值比[OR]:0.48,95%可信区间[CI]:0.35 - 0.66,p<0.001;OR:0.70,95%CI:0.56 - 0.88,p = 0.002;OR:0.57,95%CI:0.34 - 0.95,p = 0.03)。肌酐/白蛋白比值可作为这些患者死亡率的预测指标;它有助于提前识别高危患者。